Faruqi & Faruqi, LLP Securities Litigation Partner Encourages Investors to Seek Legal Options Contact Partner James (Josh) Wilson if You Suffered Losses in Elanco If you suffered losses exceeding $100,000 in Elanco between November 7, 2023 and June 26, 2024, you may have legal options available to you. Faruqi & Faruqi partner Josh Wilson is…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In iLearningEngines To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in iLearningEngines between April 22, 2024 and August 28, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi…
Welcome to the Faruqi & Faruqi, LLP Securities Litigation Blog! Have you suffered losses exceeding $50,000 in Allarity? Hey there, fellow investor! If you’ve found yourself in the unfortunate position of suffering losses exceeding $50,000 in Allarity between May 17, 2022, and July 19, 2024, you’re not alone. We know how frustrating and disheartening it…
Eastern Bankshares, Inc. (NASDAQ:EBC) recently held its Third Quarter 2024 Earnings Conference Call on October 25, 2024, at 9:00 AM ET. The call featured key company executives including Bob Rivers, the Executive Chair & Chair of the Board; Denis Sheahan, the Chief Executive Officer; and David Rosato, the Chief Financial Officer & Treasurer. Conference call…
Welcome to the Ansys Awards Extravaganza! Hey there, tech enthusiasts! Have you heard the latest news about Ansys sweeping the TSMC 2024 OIP Partner of the Year awards? That’s right, they took home not just one, not two, but four shiny trophies, all for their outstanding multiphysics analysis solutions that are revolutionizing the world of…
Investors Alert: Sage Therapeutics, Inc. Securities Litigation Act Now to Protect Your Rights Are you an investor who suffered losses exceeding $75,000 in Sage Therapeutics, Inc. between April 12, 2021, and July 23, 2024? If so, you may have legal options available to you. Faruqi & Faruqi, LLP partner James (Josh) Wilson is here to…
Psyence Group Announces Partnership with Empax Center for Clinical Trial New Developments in Mental Health Treatment Empax Center brings significant expertise in clinical trial execution for mental health and neurological conditions. Psyence Biomed is on track to begin recruitment this quarter and to announce Adjustment Disorder topline data in the second half of 2025. Yesterday,…
Homerun Resources Inc. Announces Private Placement Increase Vancouver, British Columbia–(Newsfile Corp. – October 25, 2024) – Homerun Resources Inc. (TSXV: HMR) (OTCQB: HMRFF) (“Homerun” or the “Company”) is pleased to announce that, further to the news release dated October 16, 2024, the Company will now issue 1,675,054 units (the “Units”), for aggregate gross proceeds of…
